APOE and Alzheimer disease: To analyze which factors might influence plasma p‐tau181 levels, we ran a multiple backward regression analysis, considering diagnosis (SCD, MCI, AD dementia), age at plasma collection, Core1 status, impaired renal function, and APOE genotypes as covariates.